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Trigeminal ophthalmic placodeTrigeminal sensory neurons develop from the neural crest and neurogenic placodes, and have been studied as a
principal model of sensory neuron formation. While the Notch pathway has been extensively characterized in
central nervous system development and other developmental processes, it has not been well characterized in
sensory neurogenesis. Herewe studied the functional role of Notch signaling in the trigeminal ophthalmic (opV)
placode, a prime model of sensory neurogenesis. To establish a good spatiotemporal description of Notch
pathway genes in the chick trigeminal placode, a stage-speciﬁc expression analysiswas conducted, showing that
expression of most Notch pathway genes and effectors are expressed in the placode, with expression primarily
being conﬁned to ectodermal cells. Expression was highest at stages of peak neuronal differentiation. To test the
function of Notch signaling in opV placode cell differentiation, Notch receptor cleavage was blocked using the
gamma-secretase inhibitor, DAPT, or signalingwas activated bymisexpression of the Notch intracellular domain
(NICD). Notch activation resulted in a signiﬁcant reduction in sensory neurogenesis. Cells remained in the
ectodermanddid not differentiate. Expression of the opV speciﬁcationmarker Pax3was also lost in targeted cells.
DAPT exposure resulted in a dramatic increase in neurogenesis without increasing proliferation, where many
differentiated cells were found in the mesenchyme and, surprisingly, within the ectoderm. This is the ﬁrst result
clearly showing proliﬁc neuronal differentiation in the ectoderm of the trigeminal placodes after experimental
manipulation of a molecular signaling pathway, thus identifying Notch signaling as a primary regulator of the
sensory neuron fate in the opV placode.d Developmental Biology, 574
. Fax: +1 801 422 0700.
.
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In vertebrates, the neurogenic placodes and a subset of neural crest
cells give rise to all peripheral sensory neurons (D'Amico-Martel and
Noden, 1983). Sensory neurons are the sole derivative of the trigeminal
placode (Baker andBronner-Fraser, 2001; Schlosser, 2006),making it an
excellent system to investigate a direct path to sensory neurogenesis.
The trigeminal placodeconsists of twomolecularly distinct placodes, the
ophthalmic (opV) and the maxillomandibular (mmV). The opV and
mmV placodes each contribute neurons to the distal region of their
respective ganglionic lobes, while the neural crest contributes proximal
neurons, aswell as glial cells (Baker andBronner-Fraser, 2001;D'Amico-
Martel andNoden, 1983; Schlosser, 2006). Since identiﬁcationof Pax3 as
a molecular marker of the opV placode (Stark et al., 1997), several
studies have followed describing the tissue interactions and key
signaling pathways involved in opV development. Baker et al. (1999)
characterized the timing and tissue interactions involved in the
competence, induction, and speciﬁcation of the opV placode. Subse-
quent experiments showed that Pax3 expression in opV placodalectoderm correlates with speciﬁcation and commitment to an opV
cutaneous sensory neuron fate, suggesting a one-step induction in
which neuronal subtype identity is coupled to neuronal differentiation
(Baker and Bronner-Fraser, 2000; Baker et al., 2002). These and other
early studies also identiﬁed important ligands and receptors in opV
ectoderm: FGFR4, Frizzled 1, 2, and 7, and Delta1 (Begbie et al., 2002;
Stark et al., 1997, 2000). A functional analysis of the Wnt and Fgf
pathways in opV development, as well as PDGF, has recently been
described (Canning et al., 2008; Lassiter et al., 2007, 2009; McCabe and
Bronner-Fraser, 2008). The canonical Wnt signaling pathway was
shown to be necessary but not sufﬁcient for opV placode cell fate
determination, maintenance, and differentiation (Lassiter et al., 2007).
The FGF pathway was also found to be essential for opV placode cell
delamination and differentiation, but did not have the ability alone to
direct placode development (Lassiter et al., 2009). However, whenWnt
and FGF signals were misexpressed in the isthmus, they were found to
work in concert to induce trigeminal placode development (Canning
et al., 2008). Platelet-derived growth factor (PDGF), via the neural tube,
was also shown to be necessary for induction of the opV placode and is
sufﬁcient for a moderate increase in the number of opV neurons in the
condensing ganglion (McCabe and Bronner-Fraser, 2008).
OpV placode cells become speciﬁed coincident with expression of
the transcription factor Pax3. These Pax3+ cells quickly become
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(Begbie et al., 2002; Graham et al., 2007; McCabe et al., 2009). The opV
neuroblasts then delaminate from surrounding ectoderm and enter
the mesenchyme, upregulating neuronal differentiation genes such as
Islet1, NeuN, and Neuroﬁlament. Inhibition of the Wnt or FGF
pathway prevents opV cells from delaminating from the ectoderm.
Once stalled in the ectoderm these cells never continue down the
differentiation pathway and even downregulate the opV speciﬁcation
marker Pax3 (Lassiter et al., 2007, 2009). Even Pax3 misexpression in
the ectoderm only promoted upregulation of FGFR4 and Ngn2 and did
not lead to delamination or neuronal differentiation (Dude et al.,
2009). Because misexpression of the Wnt, FGF or PDGF pathways did
not promote broad ectodermal neurogenesis, and Pax3 misexpression
only promoted upregulation of FGFR4 and Ngn2, we hypothesized
that additional modulators are necessary for terminal differentiation,
with the most likely candidate being Notch/Delta signaling.
The Notch/Delta pathway is important to many developmental
processes including neural progenitor maintenance and differentiation
in the CNS, somite formation, hematopoiesis, angiogenesis, and is also
misregulated in certain cancer types (Bolós et al., 2007; Cheung et al.,
2006; Fiúza and Arias, 2007; Karamysheva, 2008; Lasky and Wu, 2005;
Pourquie, 2001; Weng et al., 2003). Generally, Notch signaling acts to
maintain stem cells, laterally inhibit cell fate, and laterally induce
boundary formation. The Notch pathway has been shown to regulate
avian trunkneural crest cell fatedetermination in thedorsal root ganglia
(Wakamatsu et al., 2000). In the CNS, manipulation of the Notch
pathway via Notch1 and RBPjK knockout mice, the gamma-secretase
inhibitorDAPT, or dominant-active and dominant-negativeDelta, result
in premature differentiation of neuronswhenNotch signaling is blocked
and inhibition of the neuronal fate when Notch signaling is activated
(Bolós et al., 2007; Yoon andGaiano, 2005; Abelló et al., 2007; Daudet et
al., 2007; Nelson et al., 2007; Kageyama et al., 2005; Lewis, 1998).
Recently, studies aimed at decipheringhowNotch signaling functions in
mammals has challenged and enhanced the classical view of lateral
inhibition ﬁrst described in Drosophila (Heitzler and Simpson, 1991;
Muskavitch, 1994). Real-time imaging in the CNS ofmouse embryos has
revealed a dynamic oscillatory expression of Delta-like ligand 1 (Dll1),
Hes1, andNgn2 (Shimojo et al., 2008). This study suggests that themain
functionofNotch signaling is to dynamicallymaintainneural progenitor
cells (Kageyama et al., 2008; Shimojo et al., 2008). Thus, while Notch
signaling has been well studied in various developmental systems,
including neuronal cell fate in the CNS, surprisingly, little is known
regarding Notch/Delta signaling in sensory neurogenesis. Only a few
Notch pathway components have previously been described as being
expressed in the trigeminal placodes. Work on Notch signaling in the
peripheral nervous system has been done in the otic placodes, where
some functional studies have shown that Notch/Delta acts to regulate
the choice between hair-cell and supporting cell, maintain prosensory
patches and inﬂuence otic placode size (Daudet and Lewis, 2005;
Daudet et al., 2007; Jayasena et al., 2008). Our aims were to identify a
functional role for Notch/Delta signaling in opV placode sensory
neurogenesis.
In this study, we provide a detailed spatiotemporal description of
Notch pathway genes in the trigeminal placodes. During opV placode
development, all Notch ligands, receptors, and effectors assayed are
conﬁned to the ectoderm, and therefore function prior to delamination.
From these data we propose that a key step in neuronal selection is
regulated by Notch signaling. We tested this hypothesis by manipulating
the Notch pathway using DAPT to block Notch signaling, and the Notch
intracellular domain (NICD) to constitutively activate the pathway in the
chick head. We show that blocking Notch signaling promotes precocious
neurogenesis in all opV speciﬁed Pax3+cells,with an increase inneurons
both within the ectoderm where minimal neuronal differentiation
typically occurs, and in the mesenchyme pool. In contrast, constitutive
Notch signaling completely disrupted development of opV placode cells,
preventing neuronal differentiation and cellular delamination.Materials and methods
Expression reagents
The NICD-pCIG and control pCIG-GFP constructs were a kind gift
from Andy McMahon and Sean Megason. All expression constructs
were prepared for electroporation by resuspending at a concentration
of 4–6 μg/μl in water with fast green added for visualization.
In ovo electroporation
Fertilized chicken (Gallus gallus) eggs were obtained from local
farms and incubated to the desired stage in a humidiﬁed incubator at
38 °C. The DNA constructs described above were electroporated into
10–12 ss chicken embryos using vertical electroporation, where the
reference electrode was placed underneath the embryo through a
small hole made outside the area opaca, and the driving electrode was
placed directly above the area of interest (BTX 820 electroporator
from Genetronics: ﬁve 10 ms pulses of 10 V each, one second gap
between each pulse). Embryos were then allowed to develop for 30 h
before being harvested.
DAPT head cultures
Head regions above the otic vesicle were dissected from 13 to 15
ss embryos using a micro-scalpel. Tissues were stored in complete
medium on ice (10% fetal bovine serum, 2% chick embryonic
extract in DMEM) until required, then rinsed in sterile DMEM before
transplantation into collagen gels. Collagenmatrix gels were prepared
as previously described (Groves and Bronner-Fraser, 2000). Brieﬂy,
90 μl of collagen solution and 10 μl of 10× DMEM were combined
followed by addition of 4.5 μl of 7.5% sodium bicarbonate to adjust the
pH to 7.5. 30 μl drops of the prepared collagen solution were plated
and allowed to set. Head regions were then placed on top of the
collagen mound followed by 20 μl of collagen solution added to cover
tissue. DMEM (1 ml) with N2 supplement (GIBCO) and antibiotic
were added with either DAPT (100 μM) or DMSO vehicle. Cultures
were grown at 37 °C and 5% CO2 for 12–24 h. Cultures were ﬁxed in 4%
formaldehyde and prepared for cryosection.
Whole-mount in situ hybridization
Digoxygenin (DIG)-labeled RNA antisense probes were synthesized
from plasmids containing fragments or complete cDNA of the following
chicken genes: cDelta1, cLunatic Fringe, cNotch1, cSerrate1 (Daudet et al.,
2007), cHairy1, and cHairy2 (obtained fromD.Henrique, Universidade de
Lisboa, Portugal). DIG-labeled RNA antisense probes were synthesized
from PCR ampliﬁcation of chick cDNA of the following chicken genes:
cDelta4, cHes5, cNgn2 (Lassiter et al., 2009), and cNotch2. The following
primers were used for the respective genes: cDelta4, outer
primers (forward 5′-TGTGCCGAACAGAATGGATA-3′ and reverse 5′-
TACCTTGACCCACTTGACCT-3′) and inner primers (forward 5′-GAGTG-
CATCTGTCGTTCTGG-3′ and reverse 5′-TTGAACGACGAGAGTCCACC-3′),
cHes5, outer primers (forward 5′-GAGCCAGCTTCGTGCTGA-3′ and
reverse 5′-TGTGACCACGTGTAAGGTCT-3′) and inner primers (forward
5′-CTGACAGCAGCTCTCGGATA-3′ and reverse 5′-AGTGGTAGTG-
GACCTGTGAC-3′), cNotch2, outer primers (forward 5′-ACCGAAGTG-
GACGTCAGAAC-3′ and reverse 5′-GAACACGGTCCACACAGACA-3′) and
inner primers (forward 5′-CCAGGATGGAAATGAAGAACC-3′ and reverse
5′-GAAGGAGCTCTGTGTGGACC-3′). Whole-mount in situ hybridization
was performed in chick embryos as described by Henrique et al. (1995).
Brieﬂy, formaldehyde-ﬁxed embryos of appropriate developmental
stages were buffered and exposed to a DIG-labeled antisense RNA
probe, which recognized the speciﬁc mRNA transcripts. After removal of
the non-speciﬁcally adhering probe, the embryos were incubated with
anti-DIG alkaline-phosphatase (AP) antibody (1/2000; Roche), followed
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speciﬁc mRNA transcripts were cryosectioned (12 μm) and mounted for
immunohistochemistry and section analysis.
Immunohistochemistry and analysis
The following primary antibodies were used: Pax3 (1:1000, mouse
IgG2a; DSHB), Islet1 (1:200, mouse IgG2b; DSHB), Neuroﬁlament
(1:300, mouse IgG1; DSHB), phosphohistone H3.3 (1:100, rabbit
polyclonal IgG; Upstate). The Developmental Studies Hybridoma Bank
(DSHB) was developed under the auspices of the NICHD and is
maintainedby theUniversity of Iowa,Departmentof Biological Sciences,
Iowa City, IA 52242. Appropriately matched Alexa488-, Alexa546- or
Alexa633-conjugated goat anti-mouse or goat anti-rabbit secondary
antibodies were obtained fromMolecular Probes/Invitrogen.
For immunohistochemistry on cryosections, embryos were em-
bedded in gelatin and cryosectioned to generate 10–12 μm sections of
the area of interest. Sections were mounted on Superfrost® Plus glass
slides and the gelatin was removed by treating the slides in
phosphate-buffered saline (PBS) at 37 °C for 15–20 min. The slides
were incubated overnight at 4 °C in primary antibody, diluted in
antibody buffer (PBS, 0.1% bovine serum albumen and 0.1% Tween),
followed by incubation for 1 h at room temperature in secondary
antibodies diluted in antibody buffer. Three 5–10 minute washes in
PBS followed each incubation. Slides were mounted in Fluoromount G
(SouthernBiotech). Sections were analyzed using epiﬂuorescent
microscopy; photographs from different channels were superimposed
using Adobe Photoshop or Olympus Microsuite to observe over-
lapping expression.
For quantitative analysis, cells from ﬁve random sections of each
opV placode/ganglion were analyzed to minimize variability and bias
and averaged to produce a standard mean for each independent
placode/ganglion (Lassiter et al., 2007). Embryos displaying obviously
unhealthy tissue morphology were excluded from the data set, and
only embryos where DAPI stained nuclei were intact without any
apparent degradation were included. Positive cells were determined
and counted using Olympus Microsuite software to identify cells with
minimum color thresholds. Statistical analysis was performed, with p-
values calculated using Student's t-test to compare the standard
means of control and experimental samples.
Results
Notch pathway genes are expressed during opV placode development
Prior to this study, a spatiotemporal description of the Notch
pathway genes in the chick opV placode was not available. A stage-
speciﬁc analysis of the Notch pathway genes was necessary to better
understand this signaling pathway in the opV placode. To accomplish
this we compared the mRNA expression of Notch1, Notch2, Delta1,
Delta4, Serrate1, Lunatic fringe, Hes1, Hes2, and Hes5 to Ngn2 at different
developmental stages (see Table S1). Ngn2 is a proneural cell marker in
the opV placode (Begbie et al., 2002) and functions in the Notch
signaling pathway. Ngn2 directly induces expression of Delta1 (Castro
et al., 2006) and its expression is repressed by the Notch effector, Hes1
(Shimojoet al., 2008).Ngn2wasﬁrst expressed in the opVplacodeatHHFig. 1.Notch pathway gene expression in trigeminal placode development. Notch1mRNA is e
Notch1 mRNA expression appears more intense in ectodermal cells (E) at HH stages 12–13 (
expressed at low levels in ectodermal cells of the midbrain region (G). Delta1 mRNA expr
expression appears slightly fainter by HH stage 17 (I). Serrate1mRNA is not expressed in th
low levels in ectodermal cells of the midbrain region at HH stages 10–11 (Q). At HH stages 12
by HH stage 17 (S). Hes1mRNA expression was detected at low levels in the midbrain ectod
(Y) at HH stages 12–13 (W) and faint expression was detected at HH stage 17 (X). Ngn2mRN
11 (AA). Ngn2mRNA expression levels are most easily detected at HH stages 12–13 (BB, DD
ectoderm at HH stage 9 (A, F, K, P, U).stages 10–11 (Fig. 1AA)withmore robust stainingobserved in a broader
region by stages 12–13 (Figs. 1BB, DD), and expressionwas less obvious
by stage 17 (Fig. 1CC). Other Notch signaling pathway genes were
not expressed in the opV placode at stage 9 (Fig. 1). However, by stages
10–11 (Fig. 1B), Notch1 was expressed in the opV domain within the
ﬁeld marked by Ngn2, and became more apparent by stages 12–13
(Figs. 1C, E). At stage 17,Notch1 expressionwas reduced (Figs. 1D, S2A).
Notch2 was expressed in a similar pattern as Notch1 (Figs. S1a–c) At
stages 10–11 (Fig. 1G), Delta1was highly expressed in a few individual
cells. By stages 12–13 expression was diffuse throughout the placode,
with strongexpression in several individual cells (Figs. 1H, J). Expression
was less obvious by stage 17 (Figs. 1I, S2C). Lunatic fringe expressionwas
similar to the expression of Delta1 (Figs. 1Q–T, S2E). Serrate1 was
expressed caudal to the opV placode in the hindbrain ectoderm and
never expressed in the trigeminal placode (Figs. 1l–O). Delta4 was not
expressed in the opV placode at any of the analyzed stages (Figs. S1d–f).
Notch signalinghas been shown toactivate the transcription ofHes1 and
Hes5 (Bailey and Posakony, 1995; Jarriault et al., 1995, 1998; Ohtsuka
et al., 1999). Hes1 was expressed in the opV placode at stage10–11
(Fig. 1V), expression increased and was scattered by stages 12–13
(Figs. 1W, Y) and became less obvious by stage 17 (Figs. 1X, S2G). It had
a similar pattern as Notch1. Hes2 was expressed in the opV placode at
stages 11–12 (Figs. S1h, S1i), stage 13 (data not shown), and stage 17
(data not shown). Hes5 was not expressed in the opV placode at any
stage (Figs. S1j–l). A table describing the expression of each gene
provides additional detail (Table S1).
Using Pax3 as a marker for the opV placode and ganglion, we show
that Pax3 protein expression overlaps the Delta1 domain in the
ectoderm, at stages 13 and 17 of chick development (Figs. 2A–F), also
individual cells expressing high levels ofDelta1 express Pax3 at stage 13
(Figs. A–C, arrow). It is important to note that expression of Notch
pathway genes and effectors are conﬁned primarily to the ectoderm,
being downregulated upon EMT,with faint expression or no expression
in mesenchyme cells. In addition, no Notch pathway gene expression
tested was expressed in the opV ganglion (Fig. S2A–H). This indicates a
distinct difference in the differentiation state between opV ectoderm
and mesenchyme cells.Inhibition of Notch signaling leads to premature neuronal differentiation
in the opV placode
In the opV placode, the vast majority of Pax3+ cells do not express
neuronal markers nor do they start to differentiate until they begin
delaminating from the ectoderm. The spatiotemporal expression of the
Notchpathwaygenes suggests thatNotch signalingmaydetermineEMT
initiation and neuronal selection. To test this, we blocked Notch
signaling using the gamma-secretase inhibitor, DAPT, in chick head
explant cultures (Abelló et al., 2007; Daudet et al., 2007; Nelson et al.,
2007). The heads of 13–15 ss chick embryos were removed rostral to the
otic vesicle equator and embedded in collagen. These collagen-embedded
explants were cultured in DAPT or DMSO for 12 or 24 h, to about the 20–
22 or 30–32 ss, respectively. Embryo heads were then sectioned and
immunostained for the opV marker Pax3, the early neuronal marker
Islet1, and the later neuronal differentiation marker Neuroﬁlament (NF),
which primarilymarks axonal projections. In explants incubated for 12 h,
DMSO control embryos showed very few Pax3+ opV cellsxpressed at low levels in ectodermal cells of themidbrain region at HH stages 10–11 (B).
C) and the expression is faint by HH stage 17 (D). At HH stages 10–11, Delta1mRNA is
ession levels appear more intense in ectodermal cells (J) at HH stages 12–13 (H) but
e ectodermal cells (K–O) of the trigeminal placode. Lunatic fringe mRNA is expressed at
–13, Lunatic fringe expression appears more robust in ectodermal cells (R, T) but is faint
erm at HH stages 10–11 (V). Hes1 expression appears intense in the midbrain ectoderm
A expression was detected at moderate levels in the trigeminal placode at HH stages 10–
) and are more faint by stage 17 (CC). Notch signaling was not detected in the midbrain
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Fig. 2. Delta1 gene expressiondomainoverlapswith Pax3 protein expression. AtHH stage 13,Delta1 is expressed in the ectoderm (A), and atHH stage 17, residualDelta1 staining is shown
in the ectodermwithnoobvious expressionofDelta1 in the formedganglion (D). Pax3 protein is expressed in the ectodermandmigrating cells atHHstage 13 (B), and atHH stage17,most
Pax3+ cells have left the ectoderm aggregating in the formed ganglion (E). At HH stage 13, individual cells expressing higher levels of Delta 1 also express Pax3 (C, arrow).
Fig. 3.Notch inhibition leads toprematureneuronaldifferentiation in theectoderm. Transverse sections through theophthalmic trigeminal (opV) placode regionof a 20–22 ss embryo. The
heads were cultured in either DMSO or DAPT for 12 h, harvested, cryosectioned, and immunostained for the opV marker Pax3 (A,E), the early neuronal marker Islet1 (D,F), and the late
neuronal marker Neuroﬁlament (C,G). DMSO treated embryos showed normal opV placode development (A–D). DAPT treated embryos showed an increase in ectodermal Pax3+ cell
coexpressing Islet1, and thenumber of Pax3+/Islet1+mesenchymal cellswas alsodramatically increased (E,F,H). DMSOandDAPT treated embryos showednoNeuroﬁlament expression
in the ectoderm or in the mesenchyme (C,G).
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D), while DAPT treated embryos showed many Pax3+/Islet1+ cells in
the ectoderm andmesenchyme (n=16; Figs. 3E–H). Therefore, blocking
Notch signaling for 12 h is sufﬁcient to promote cells toward a sensory
neuron cell fate. Importantly, NF expression was rarely observed in the
ectoderm of DMSO treated embryos, was observed somewhat in the
mesenchyme of DAPT treated embryos, but again only minimally in
the ectoderm at this early stage; indicating that most cells are in a state
of early neuronal differentiation, expressing only Islet1 and not Neuro-Fig. 4. Notch inhibition leads to ectopic neuronal differentiation. Transverse section throug
heads were cultured in either DMSO or DAPT for 24 h, harvested, cryosectioned, and immuno
treated embryos showed normal opV placode development (A–C). DAPT treated embryos sho
Pax3+/Islet1+ mesenchymal cells was also dramatically increased (D–F). Histogram des
mesenchyme, and Pax3+/Islet1+ mesenchyme in DMSO vs. DAPT cultures (F). Error barsﬁlament. Normal NF expression was observed in other tissues such as
in the eye and the neural tube. This supports prior studies showing, in
the ear for example, that Islet1 precedes neuronal Beta-tubulin (TuJ1)
expression, which in a separate study, was shown to precede NF
expression (Memberg and Hall 1995; Radde-Gallwitz et al., 2004; Bell
et al., 2008).
To further characterize the premature neurogenesis in DAPT
treated embryos, we performed a more detailed analysis on embryos
treated for 24 h when both experimental and control embryosh the ophthalmic trigeminal (opV) placode region of a 30–32 ss embryo. The 13–15 ss
stained for the opVmarker Pax3 (A,D) and the early neuronal marker Islet1 (B,E). DMSO
wed a signiﬁcant increase in ectodermal Pax3+ cells coexpressing Islet1, the number of
cribing total number of cells for Pax3+ ectoderm, Pax3+/Islet1+ ectoderm, Pax3+
depict SEM.
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expressing cells in opV placodal ectoderm at 24 h did not
signiﬁcantly increase in DAPT treated embryos (129.2 cells, SEM
+/−13.0, n=25; Figs. 4D,G) compared to DMSO controls (121.1
cells, SEM+/−10.6, n=25; Figs. 4A,G), meaning the placode
domain did not expand signiﬁcantly. However, Notch signaling did
appear to greatly affect neuronal differentiation within the opV
ectodermal pool, evidenced by a dramatic upregulation of Islet1
expression in opV placodal ectoderm cells in DAPT embryos vs.
DMSO control embryos. Control embryos had an average of 9 cells
(SEM+/−1.2, n=25) with co-localization of Pax3 and Islet1,
whereas DAPT explants had 119.6 cells (SEM+/−12.0, n=25)
with nearly all Pax3+ ectoderm cells also coexpressing Islet1
(pb0.0000001; Fig. 4). The number of delaminated Pax3+ cells
found in the mesenchymal pool did increase considerably, where
DMSO controls averaged 75.9 cells (SEM+/−7.8, n=25; Figs. 4A,G)
compared to 188.1 cells in DAPT explants (SEM+/−10.7, n=25,
pb0.00007; Figs. 4D,G). In non-experimental embryos, Islet1 is
expressed in only a few ectoderm cells at low levels, but is seen at
higher levels in delaminating cells and in mesenchyme cells, where
nearly all Pax3+ cells in the mesenchymal pool coexpress Islet1. This
mesenchymal expression was also seen in experimental explants but
in much greater numbers, with nearly all additional Pax3+ cells also
expressing Islet1. Control embryos had 64.9 cells (SEM+/−6.7,
n=25) coexpressing Pax3/Islet1 in the mesenchyme while DAPT
embryos had 171.1 Pax3+/Islet1+ cells (SEM+/−15.0, n=25,
pb0.00007; Fig. 4). In DMSO control explants, NF was seen projecting
from Pax3+ opV cells in the mesenchyme and was absent from the
ectoderm (n=10/10; Figs. 5A–C). Experimental DAPT explants
(n=11/11; Figs. 5D–F) showed precocious NF expression projecting
from Pax3 cells throughout the ectoderm and mesenchyme. The
number of Pax3+ cells in the mesenchyme was increased, as
previously seen, and also led to increased NF protein in the
mesenchyme when compared to controls. Preventing Notch signaling
therefore increases neurogenesis signiﬁcantly in the opV placode.
These data together clearly show that without activation of NotchFig. 5. Notch inhibition causes formation of additional differentiated neurons. Transverse sec
13–15 ss heads were cultured in either DMSO or DAPT for 24 h, harvested, cryosectione
Neuroﬁlament (B,E). DMSO treated embryos showed normal opV placode development (A
ectodermal and mesenchymal Pax3+ cells, demonstrating enhanced neuronal differentiatisignaling, Pax3+ opV speciﬁed cells will undergo neurogenesis
regardless of the ectoderm/mesenchyme location.
In addition, we also observed precocious neurogenesis caudal to the
opV placode in the presumptivemmVplacode.While no distinct marker,
such as Pax3, has been identiﬁed for these cells, many ectodermal and
mesenchymal Islet1+cellswere readily visible immediately caudal to the
Pax3+ domain (data not shown).
Blocking Notch signaling reduces proliferation in opV ectoderm
To further clarify the previous DAPT result showingmore than double
the number of Pax3 cells in the mesenchyme, we considered the
possibility that increased proliferation could also account for this
phenotype. Explant experiments were repeated and immunostained for
the mitotic marker phosphohistone-3 (PH3). In DMSO control explants,
many cells in the opV ectoderm were dividing, with an average of 10.0
cells expressing PH3 (SEM+/−2.6, n=5; Figs. 6A–C,G). Whereas, in
DAPT explants, an average of only 1.6 cells in the placode domain
expressed PH3 (SEM+/−0.4, n=8; Figs. 6D–G). This demonstrated a
statistically signiﬁcant decrease of proliferating cells in embryos where
Notch signaling was inhibited (pb0.025). This supports the idea that
blocking Notch activation leads to premature neurogenesis, prompting
cells to exit the cell cycle early. Interestingly, ectodermal cells in both
control andexperimental embryos that didexpress PH3didnot coexpress
Pax3. This conﬁrms previous studies which found that the onset of Pax3
expression is coincident with cells becoming post mitotic neuroblasts
(Begbie et al., 2002; Graham et al., 2007; McCabe et al., 2009).
Notch inhibition does not affect Ngn2 proneural gene expression in the
opV placode
Neurogenin2 is a proneural transcription factor, expressed in early
sensory neurons (Fode et al., 1998; Ma et al., 1998). The ophthalmic
trigeminal placode gives rise to sensory neurons of the trigeminal
ganglia. The proneural cells of the opV placode are marked by Ngn2
expression at the 10ss, typically localized to the ectoderm (Begbietion through the ophthalmic trigeminal (opV) placode region of a 30–32 ss embryo. The
d, and immunostained for the opV marker Pax3 (A,D) and the late neuronal marker
–C). DAPT treated embryos showed a signiﬁcant increase in expression of NF in both
on (D–F).
Fig. 6.Notch inhibition results indecreasedproliferation in theopVplacode. Transverse section through theopVplacode regionofa30–32ss embryo.DMSO/DAPTheadcultureswere repeated,
and immunostained for the mitotic marker phosphohistone-3 (PH3; A,D) and Pax3 (B,E). DMSO treated embryos showed signiﬁcantly more PH3+ cells in the opV domain (A–C) vs. DAPT
treated embryos which showed signiﬁcantly fewer PH3+ cells (D–F). Histogram describing total number of PH3+ cells in the opV placode domain (G). Error bars depict SEM.
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Upon activation of Notch signaling, Hes1 is transcribed and binds to
the promoter of Ngn2, thereby blocking expression. To test whether
inhibiting Notch signaling in the chick head could upregulate Ngn2 or
expand the domain, we repeated DAPT (n=11) and DMSO (n=9)
head cultures and performed whole-mount in situ hybridization for
Ngn2 mRNA. Following in situ hybridization, explants were cryosec-
tioned and immunostained for Pax3 and Islet1. Notch inhibition did
not result in a signiﬁcant difference of Ngn2 expression in DMSO vs.
DAPT embryos (Figs. S3A–D). Ngn2 expression was not expanded
beyond the opV placode domain in experimental vs. control embryos,
indicating that placodal speciﬁcation is necessary forNgn2 expression.
Constitutive activation of Notch signaling disrupts proper development
of opV placode cells
To fully examine how Notch signaling regulates opV cell fate, our
subsequent experiments focused on constitutive activation of the Notch
pathway through electroporation of the Notch intracellular domain,
NICD. In the canonical Notch pathway, NICD translocates to the nucleus,binds to CSL and recruits Mastermind to activate target genes such as
Hes1 (Hatakeyama et al., 2004, 2006; Ohtsuka et al., 1999). Hes1 binds
to the Ngn2 promoter blocking its expression thereby preventing
neurogenesis. We electroporated NICD into head ectoderm of 10–12 ss
embryos and allowed them to develop 30 h to about the 30–32 ss. The
endpoint stage was the same as explant experiments described above,
with the starting point being slightly shifted to allow time for
transgenic expression after electroporation. Control embryos electro-
porated with the empty pCIG-GFP vector, showed normal development
in bothwhole-mount and embryo sections (Figs. 7A–E). Targeted pCIG-
GFP cells coexpressed Pax3 in the ectoderm and mesenchyme; they
also delaminated and differentiated accordingly, expressing Islet1 in
the mesenchyme. In experimental embryos electroporated with NICD,
differentiation of opV placode cells was disrupted (Figs. 7F–J). Targeted
NICD cells in the opV domain remained in the ectoderm, failing to
delaminate or differentiate; they also did not express Pax3. In control
pCIG embryos, a mean of 45.8 cells (SEM+/−10.5, n=10) in the
ectoderm coexpressed Pax3/GFP, whereas only 14.2 (SEM+/−2.8,
n=13) NICD targeted cells colocalized with Pax3 in experimental
embryos (pb0.02; Fig. 7K). This statistically signiﬁcant reduction of
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regulates Pax3 expression. Co-localization of Pax3/GFP in the mesen-
chyme of experimental embryos showed an even greater decrease due
to targeted cells failing to delaminate. Control embryos had an average
of 132.3 cells (SEM+/−22.8, n=10) in the ganglion, coexpressing
Pax3/GFP vs. 2.2 cells (SEM+/−0.6, n=13) in experimental embryos
(pb0.0003; Fig. 7K). Therefore, activation of the Notch pathway in the
opV placode led to a highly statistically signiﬁcant reduction of targeted
opV cells delaminating and contributing to the ganglion. Of interest, the
total numberof Pax3+cells in theopVganglionof experimental embryos
was also signiﬁcantly diminished (Fig. 7H) compared to pCIG controls,
indicating that untargeted ectodermdoes not retain placodal potential toFig. 7. Activation of Notch signaling inhibits opV cell delamination and neuronal differentia
image showing control GFP expression in a pattern similar to wildtype with opV placode cel
electroporated embryos show targeted cells scattered only in the ectoderm (F). Transverse se
targeted with the pCIG control construct demonstrated normal development; targeted ecto
with Pax3/Islet1 co-localization, with many cells contributing and differentiating to the gang
they did not delaminate, contribute to the ganglion, or differentiate; NICD ectoderm cells w
cells remaining in the ectoderm also downregulated Pax3 expression, and the number of u
reporting quantitative counts of total cells (K). Error bars depict SEM.compensate for the loss at this stage. Control embryos had an average of
281.6 cells (SEM+/−39.4, n=10) total Pax3+ cells in the ganglion vs.
103.9 cells (SEM+/−20.1, n=13) in experimental embryos (pb0.003).
As expected, NICD targeted opV cells that were stalled in the ectoderm
did not express Islet1. In addition, due to the lack of targeted opV cells
delaminating and contributing to the ganglion, targeted Islet1+ placode
cells were almost entirely absent in the mesenchyme (Fig. 7I). This
further demonstrates that cell-autonomous activation of Notch signaling
in opV ectoderm interferes with proper development of the placode and
prevents neurogenesis.
Because cell proliferation was downregulated after blocking Notch
signaling we investigated whether increased proliferation would occurtion. Chick embryos electroporated at 10–12 ss and incubated for 30 h. Whole-mount
ls condensing in the ganglion and extending to the ganglionic branch (A) whereas NICD
ctions through the opV placode were immunostained for Pax3 and Islet1 (C,D,H,I). Cells
derm cells were Pax3+/Islet1−, cells also delaminated and entered the mesenchyme
lion (B–E). In contrast, NICD targeted remain primarily in the ectoderm, indicating that
ere Pax3−/Islet1− and very few NICD cells ever entered the mesenchyme (G–J). NICD
ntargeted Pax3 cells contributing to the ganglion was greatly reduced (H). Histogram
845R.N.T. Lassiter et al. / Developmental Biology 344 (2010) 836–848following Notch activation. NICD electroporations were repeated and
embryos were immunostained for Pax3 and the cell proliferation marker
PH3. Targeted NICD cells remaining in the ectoderm did not show an
increase in PH3 expression when compared to pCIG control embryos
(Fig. S4). Control embryos had an average of 3.0% (SEM+/−0.65, n=9;
Figs. S4A–D) PH3+ cells in GFP targeted ectoderm and NICD targeted
cells had an average of 3.2% (SEM+/−0.42, n=9, pb0.81; Figs. S4E–I).
This ﬁnding suggests that Notch signaling may not directly regulate
proliferation in the opV placode.
To ensure speciﬁcity of both the non-cell-autonomous DAPT, and
the cell-autonomous NICD construct, we combined these treatments.
We wanted to conﬁrm that activating the Notch pathway intracellu-
larly, by directly adding NICD, would override the effect of the DAPT
gamma-secretase inhibitor which prevents cleavage of the NICD at the
cell membrane. We ﬁrst repeated the NICD/pCIG electroporations in
10–12 ss embryos and let them incubate for 4–6 h allowing time for
the transgene to be transcribed and translated. Embryos were then
collected between the 13 and 15 ss and the heads were dissected and
cultured in DAPT or DMSO as described above. Head cultures were
harvested after 24 h, cryosectioned, and immunostained for Pax3 and
Islet1. Three separate combined experiments were performed pCIG/
DAPT (n=8), NICD/DMSO (n=8), and NICD/DAPT (n=10). Each
combination had a distinct phenotype. The pCIG/DAPT controls
(Fig. 8A) had many targeted cells in both the ectoderm and
mesenchyme showing typical delamination of cells. The GFP+
targeted cells expressed both Pax3 and Islet1 in the ectoderm and
mesenchyme, as seen in the previous DAPT head cultures. The second
control, NICD/DMSO (Fig. 8B), had a phenotype similar to the NICD
electroporations above; targeted cells remained in the ectoderm
failing to delaminate. These ectoderm cells did not express Pax3 or
Islet1 and there were signiﬁcantly fewer untargeted Pax3 cells in the
mesenchyme. Untargeted ectoderm cells did continue to express Pax3
without differentiating and expressing Islet1. In NICD/DAPT experi-
mental embryos, targeted NICD cells did not delaminate or differen-
tiate, lacking both Pax3 and Islet1 expression (Figs. 8C,D). In areas ofFig. 8.NotchactivationviaNICDoverridesDAPT inhibition. Embryoswere initially electroporate
ophthalmic trigeminal (opV) placode region of a 30–32 ss embryo immunostained for Pax3 and
results as seen in separate experiments reported above, with precocious neurogenesis (pCIG
experimental combination of NICD/DAPT showed targeted NICD cells failing to delaminate and
same embryo, untargeted opV cells are Pax3+/Islet1+, similar to Fig. 2, indicating ectopic and
cells; white cells depict merge of GFP+/Pax3+/Islet1+ cells.the opV placode without targeting, the DAPT phenotype was
prevalent, with precocious premature neurogenesis in the ectoderm
and mesenchyme illustrated by Pax3/Islet1 co-localization (Fig. 8C).
This scenario conﬁrms that NICD cell-autonomous expression in the
opV placode will prevent neurogenesis even in the presence of the
chemical Notch inhibitor DAPT.
Discussion
The journey from naïve ectoderm cell to sensory neuron is a
complex developmental process that can be directly uncovered
through the study of the ophthalmic trigeminal placode. Development
of the opV placode culminates in the single cell fate choice between
sensory neuron and epidermal ectoderm. Previous ﬁndings indicate
that while several pathways (Wnt, FGF, and PDGF) are needed during
the differentiation process, none appears to be sufﬁcient to expand
the placode or generate the proliﬁc neurogenesis reported here.
Therefore, terminal differentiation of opV cells must be regulated by
an independent pathway. We hypothesize that the key step in opV
terminal differentiation is determined through juxtacrine signaling of
the Notch/Delta pathway in opV ectoderm.
Through a detailed series of gene expression snapshots, we have
characterized the spatiotemporal expression pattern of Notch ligands,
receptors, and effectors. From these data two things are clear: 1) Notch
signaling is active in opV placode cells beginning at stage 10, a
developmental timepoint coincident with opV cell fate determination
(Baker et al., 1999). 2) The expression of Notch pathway genes (a readout
for signaling activity) is conﬁned to the ectodermal pool and down-
regulated as cells undergo EMT. This is observed in both Notch-active
(Notch1, Hes1, etc.) and Notch-inactive (Ngn2, Delta; conﬁrming Begbie
et al., 2002a) cells. While candidate Notch/Delta partners are expressed
in theplacode, the speciﬁcmolecules involvedhavenotbeendetermined.
However, this mRNA expression analysis supports the hypothesis that
Notch signaling may regulate neuronal selection and cellular delamina-
tion in the placode.dwithNICDorpCIG followedbyDAPTorDMSOtreatment. Transverse sections through the
Islet1. Both control combinations pCIG/DAPT (A) and NICD/DMSO (B) showed predicted
/DAPT) and inhibited delamination and differentiation (NICD/DMSO), respectively. The
Pax3−/Islet1− even in the presence of the Notch inhibitor DAPT (D). In sections from the
increased neurogenesis (C). Magenta cells illustrate co-localization of Pax3+ and Islet1+
846 R.N.T. Lassiter et al. / Developmental Biology 344 (2010) 836–848To test this, we utilized the gamma-secretase inhibitor, DAPT,
which blocks Notch signaling. Our results show that Notch inhibition
resulted in premature and seemingly unrestrained neuronal differ-
entiation in the ectoderm of the opV placode, which has never before
been reported. Within 12 h of DAPT exposure, several opV placode
cells have aberrantly delaminated and upregulated the early neuronal
marker Islet1. In embryos exposed to DAPT for 24 h, many additional
placode-derived cells are found in the mesenchyme, expressing both
Islet1 and Neuroﬁlament. While previous reports have shown that
Islet1 is expressed in the placodal ectoderm (Shiau et al., 2008), we
observed a profound increase in neuronal differentiation within the
ectoderm, with widespread expression of both Islet1 and Neuroﬁla-
ment. Still, the number of Pax3+ ectoderm cells did not increase, and
the opV domain did not appear to be expanded. To explain the
massive increase in mesenchymal opV neurons, we ﬁrst eliminated
the possibility that blocking Notch signaling increased proliferation in
the placode. We actually found a highly signiﬁcant decrease of
proliferative cells in the opV domain, again pointing to premature
neurogenesis. We propose that the opV placode domain is tightly
regulated in the ectoderm within a subset of speciﬁed Pax3+ cells,
meaning signaling independent of Notch/Delta acts to retain the
placode within a speciﬁc domain, or otherwise limit the number of
speciﬁed (Pax3+) cells that can be regulated by Notch signaling. This
model is also supported by our analysis of Ngn2 in DAPT embryos.
Blocking Notch signaling did not increase or expand Ngn2 expression
laterally beyond the normal placode domain. This may be due to Pax3
directly activating Ngn2 as seen in mice, where Pax3 in the neural
tube regulates Ngn2 expression by directly binding to its promoter
(Nakazaki et al., 2008). Therefore, in experimental embryos, once
neuronal selection occurs and neurons leave the ectoderm, additional
opV cells can be speciﬁed from nearby competent ectoderm, and they
will upregulate Pax3, adopting the potential to undergo neuronal
differentiation and delamination. This continual recruitment would
be possible because of the accelerated neurogenesis due to global
Notch inhibition. One possible scenario in normal development,
where differentiation and cellular delamination is only occurring in a
select number of cells, is once neuronal selection has occurred, the
Delta expressing cell will delaminate thereby allowing the ectodermal
ﬁeld to reset itself and select other Pax3+ cells to differentiate.
To further examine the role of Notch signaling, and to conﬁrm the
speciﬁcity of DAPT in blocking Notch cleavage rather than another
gamma-secretase target, we constitutively activated the Notch pathway
through electroporation of the cell-autonomous NICD construct. Notch
activation resulted in targeted cells failing to delaminate or differentiate in
the ectoderm. NICD electroporations also revealed that Notch signaling
negatively regulates Pax3 expression. The loss of differentiated neurons
resulted in abnormal opV gangliogenesis, with a signiﬁcant reduction of
Pax3+ neurons contributing to the ganglion. These combined effects are
similar to those seen in previous experimental results where the Wnt or
FGF pathwayswere blockedwherewe have shown that opV speciﬁcation
canbe reversed throughPax3downregulation (Lassiter et al., 2007, 2009).
These results indirectly supported the conclusion that DAPT treatment
blocked Notch cleavage, but to ensure speciﬁcity of the DAPT treatments,
performed experiments wherein NICD electroporated embryos were
subsequently treated with DAPT in explant culture conditions. In all
embryos tested, NICD intracellular activation of the Notch pathway was
dominant, meaning targeted cells did not become neurons, whereas
untargeted placodal ectoderm cells expressed Islet1 and NF. These
ﬁndings reafﬁrmed our individual experimental results and also
conﬁrmed that DAPT is blocking Notch signaling, though it may have
additional targets.
Evidence for premature differentiation
Examining neuronal differentiation at two distinct time points
allowed us to evaluate the effects of DAPT treatment over time. After24 h, a large number of additional Islet1+ neurons are present in the
mesenchyme, and the vast majority of Pax3+ ectoderm cells also
express Islet1. Additionally, NF expression ﬁlls the placodal ectoderm
and mesenchyme, demonstrating late-stage neurogenesis. This is
different than what was observed after 12 h, where increased Islet1
expression was obvious in the Pax3+ mesenchyme cells and some
Pax3+ ectoderm cells, but many Pax3+ ectoderm cells did not yet
express Islet1, and NF was largely absent in most sections. Therefore,
treatment of the opV placode with DAPT resulted in premature
neurogenesis, the early stages being observed at 12 h where Islet1−
and Islet1+ placode cells were prevalent. By the 24 h time point,
neurogenesis had progressed rapidly and had extended into the
ectoderm, where most Pax3+ cells also expressed Islet1, and NF
expression was widespread. DMSO treated control embryos showed
very little Islet1 expression at 12 h, as very few cells had delaminated
from the undifferentiated ectoderm. At 24 h many Pax3+/Islet1−
cells still existed in the ectoderm, indicating signiﬁcant neurogenesis
had yet to occur. While past research has shown that Pax3-expressing
placode cells are largely post-mitotic from early stages of differenti-
ation, it is unclear whether a similar number of neurons would
ultimately be born in the experimental model presented here. Longer
culture techniques that allow for extended embryogenesis and yield
good tissue morphology would be required to assess total neuronal
output. Future studies will aim to test various culture conditions, and
be utilized for more detailed studies of late placode differentiation in
experimental and control treatments.
The relationship of delamination and differentiation
The observation that 24 h DAPT treatment led to precocious
neurogenesis within the surface ectoderm relates well to the question
of cellular delamination in the process of opV placode differentiation.
While ectodermally-localized neurons are occasionally observed in
control embryos (McCabe et al., 2009), the vast majority of opV
placode cells don't express Islet1 or Neuroﬁlament until after
delamination. Also, themisexpression of Pax3 causes the upregulation
of Ngn2 and FGFR4, but cells fail to delaminate and differentiate (Dude
et al., 2009). Additionally, blocking FGF signaling led to opV placode
cells remaining in the ectoderm, maintaining the expression of Pax3
for a signiﬁcant length of time, but ultimately failing to delaminate
(Lassiter et al., 2009). These observations combined indicate that
delamination is a key step for neuronal differentiation. However, in
addition to the quantitative results described here, we also saw
aberrant delamination and migration patterns in DAPT treated
embryos. In the mesenchyme, instead of individual or small groups
of cells delaminating and migrating in a stream to condense in the
interior mesenchyme as is seen in control embryos, DAPT treated
cultures showed mass delamination with neurons scattered beneath
the ectoderm. We also observed many differentiated ectoderm cells.
The observed ectoderm often appeared fragmented, indicating that
cellular adhesionwas disrupted. It is known that neurogenin regulates
the expression of neuronal differentiation genes and cell adhesion
genes directly, as shown by studies in the mouse CNS, coupling
neurogenesis with cell migration through the bHLH transcription
factor Ngn2 (Ge et al., 2006; Nakazaki et al., 2008). While our results
could lead to the conclusion that delamination is dispensable, they
also support a model wherein Notch signaling regulates both
differentiation and delamination. N-cadherin has recently been
identiﬁed as an important cell adhesionmolecule in regulating proper
gangliogenesis in the trigeminal ganglion (Shiau and Bronner-Fraser,
2009). Examining cell adhesion changes in experimental and DAPT
treated embryos will be an interesting focus of future research.
We showed that preventing Notch signaling promotes precocious
neurogenesis in all opV speciﬁed Pax3+ cells, with a dramatic
increase in the number of neurons in both the ectoderm and the
mesenchyme. In contrast, constitutive Notch signaling completely
Fig. 9. Graphical model summarizing results. Transverse section through the opV region of a chick embryo. Left side of each section represents normal development. Notch inhibition
results in proliﬁc neurogenesis in the ectodermal opV pool and an increase in the number of differentiating opV cells in themesenchyme. Notch activation prevents delamination and
differentiation and ultimately results in an ectodermal pool of unspeciﬁed cells. Legend depicts differing developmental potential of each color coded cell type.
847R.N.T. Lassiter et al. / Developmental Biology 344 (2010) 836–848disrupted the development of opV placode cells, preventing neuronal
differentiation and cellular delamination (see Model; Fig. 9). Alto-
gether the Notch expression, inhibition, and activation data demon-
strate that terminal sensory neuron differentiation and delamination
are instructed through modulation of the Notch pathway in the opV
placode. Current experiments are underway to uncover if and how the
Wnt, FGF, and PDGF pathways combine with or regulate Notch
signaling in opV placode cell differentiation, to examine changes in
cellular adhesion, and to develop strategies to evaluate later stages of
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